For Immediate Release: January 30, 2025 Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moder… [+3412 chars]Read More
FDA Approves Novel NonOpioid Treatment for Moderate to Severe Acute Pain FDAgov
